Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Aiolos collaborates with Blimp-1 to regulate the survival of multiple myeloma cells.

Hung KH, Su ST, Chen CY, Hsu PH, Huang SY, Wu WJ, Chen MM, Chen HY, Wu PC, Lin FR, Tsai MD, Lin KI.

Cell Death Differ. 2016 Jan 29. doi: 10.1038/cdd.2015.167. [Epub ahead of print]

PMID:
26823144
2.

Cross-Species, Amplifiable EST-SSR Markers for Amentotaxus Species Obtained by Next-Generation Sequencing.

Li CY, Chiang TY, Chiang YC, Hsu HM, Ge XJ, Huang CC, Chen CT, Hung KH.

Molecules. 2016 Jan 7;21(1):67. doi: 10.3390/molecules21010067.

3.

Uncovering MicroRNA Regulatory Hubs that Modulate Plasma Cell Differentiation.

Tsai DY, Hung KH, Lin IY, Su ST, Wu SY, Chung CH, Wang TC, Li WH, Shih AC, Lin KI.

Sci Rep. 2015 Dec 11;5:17957. doi: 10.1038/srep17957.

4.

Nanotechnology-based drug delivery treatments and specific targeting therapy for age-related macular degeneration.

Lin TC, Hung KH, Peng CH, Liu JH, Woung LC, Tsai CY, Chen SJ, Chen YT, Hsu CC.

J Chin Med Assoc. 2015 Nov;78(11):635-41. doi: 10.1016/j.jcma.2015.07.008. Epub 2015 Sep 14. Review.

PMID:
26383186
5.

Retinal prostheses in degenerative retinal diseases.

Lin TC, Chang HM, Hsu CC, Hung KH, Chen YT, Chen SY, Chen SJ.

J Chin Med Assoc. 2015 Sep;78(9):501-5. doi: 10.1016/j.jcma.2015.05.010. Epub 2015 Jun 30. Review.

PMID:
26142056
6.

Adenovirus pneumonia complicated with acute respiratory distress syndrome: a case report.

Hung KH, Lin LH.

Medicine (Baltimore). 2015 May;94(20):e776. doi: 10.1097/MD.0000000000000776.

7.

Risk factors for predicting visual field progression in Chinese patients with primary open-angle glaucoma: A retrospective study.

Hung KH, Cheng CY, Liu CJ.

J Chin Med Assoc. 2015 Jul;78(7):418-23. doi: 10.1016/j.jcma.2015.02.004. Epub 2015 Mar 26.

PMID:
25819708
8.

Combination therapy with intravitreal bevacizumab and macular grid and scatter laser photocoagulation in patients with macular edema secondary to branch retinal vein occlusion.

Yang CS, Liu JH, Chung YC, Chou YB, Hung KH.

J Ocul Pharmacol Ther. 2015 Apr;31(3):179-85. doi: 10.1089/jop.2014.0069. Epub 2015 Feb 25.

PMID:
25715024
9.

Assessment of retinal pigment epithelial cells in epiretinal membrane formation.

Wang LC, Hung KH, Hsu CC, Chen SJ, Li WY, Lin TC.

J Chin Med Assoc. 2015 Jun;78(6):370-3. doi: 10.1016/j.jcma.2015.01.003. Epub 2015 Feb 20.

PMID:
25708821
10.

Corneal neovascularization and contemporary antiangiogenic therapeutics.

Hsu CC, Chang HM, Lin TC, Hung KH, Chien KH, Chen SY, Chen SN, Chen YT.

J Chin Med Assoc. 2015 Jun;78(6):323-30. doi: 10.1016/j.jcma.2014.10.002. Epub 2015 Feb 14. Review.

PMID:
25687646
11.

Using induced pluripotent stem cell-derived conditional medium to attenuate the light-induced photodamaged retina of rats.

Chang HM, Hung KH, Hsu CC, Lin TC, Chen SY.

J Chin Med Assoc. 2015 Mar;78(3):169-76. doi: 10.1016/j.jcma.2014.08.017. Epub 2015 Jan 1.

12.

Stem Cell Therapy for Corneal Regeneration Medicine and Contemporary Nanomedicine for Corneal Disorders.

Hsu CC, Peng CH, Hung KH, Lee YY, Lin TC, Jang SF, Liu JH, Chen YT, Woung LC, Wang CY, Tsa CY, Chiou SH, Chen SJ, Chang YL.

Cell Transplant. 2015;24(10):1915-30. doi: 10.3727/096368914X685744. Epub 2014 Dec 12.

PMID:
25506885
13.

Applications of biomaterials in corneal wound healing.

Tsai IL, Hsu CC, Hung KH, Chang CW, Cheng YH.

J Chin Med Assoc. 2015 Apr;78(4):212-7. doi: 10.1016/j.jcma.2014.09.011. Epub 2014 Nov 10. Review.

14.

Retinal stem cells and potential cell transplantation treatments.

Lin TC, Hsu CC, Chien KH, Hung KH, Peng CH, Chen SJ.

J Chin Med Assoc. 2014 Nov;77(11):556-61. doi: 10.1016/j.jcma.2014.08.001. Epub 2014 Sep 18.

15.

The generation of induced pluripotent stem cells for macular degeneration as a drug screening platform: identification of curcumin as a protective agent for retinal pigment epithelial cells against oxidative stress.

Chang YC, Chang WC, Hung KH, Yang DM, Cheng YH, Liao YW, Woung LC, Tsai CY, Hsu CC, Lin TC, Liu JH, Chiou SH, Peng CH, Chen SJ.

Front Aging Neurosci. 2014 Aug 1;6:191. doi: 10.3389/fnagi.2014.00191. eCollection 2014.

16.

Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension.

Cheng YH, Hung KH, Tsai TH, Lee CJ, Ku RY, Chiu AW, Chiou SH, Liu CJ.

Acta Biomater. 2014 Oct;10(10):4360-6. doi: 10.1016/j.actbio.2014.05.031. Epub 2014 Jun 7.

PMID:
24914827
17.

Mitochondrial DNA association study of type 2 diabetes with or without ischemic stroke in Taiwan.

Loo JH, Trejaut JA, Yen JC, Chen ZS, Ng WM, Huang CY, Hsu KN, Hung KH, Hsiao Y, Wei YH, Lin M.

BMC Res Notes. 2014 Apr 9;7:223. doi: 10.1186/1756-0500-7-223.

18.

A temperature-induced and shear-reversible assembly of latanoprost-loaded amphiphilic chitosan colloids: characterization and in vivo glaucoma treatment.

Hsiao MH, Chiou SH, Larsson M, Hung KH, Wang YL, Liu CJ, Liu DM.

Acta Biomater. 2014 Jul;10(7):3188-96. doi: 10.1016/j.actbio.2014.03.016. Epub 2014 Mar 28.

PMID:
24681374
19.

Differential utilization of TATA box-binding protein (TBP) and TBP-related factor 1 (TRF1) at different classes of RNA polymerase III promoters.

Verma N, Hung KH, Kang JJ, Barakat NH, Stumph WE.

J Biol Chem. 2013 Sep 20;288(38):27564-70. doi: 10.1074/jbc.C113.503094. Epub 2013 Aug 16.

20.

Risk factors for progressive visual field loss in primary angle-closure glaucoma: a retrospective cohort study.

Fan NW, Hwang DK, Ko YC, Tseng FC, Hung KH, Liu CJ.

PLoS One. 2013 Jul 8;8(7):e69772. doi: 10.1371/journal.pone.0069772. Print 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk